The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Several ongoing conversations with other OEM manufactures
Demand is more than enough for competition - supply is the limiting factor. OEM deals to add. Several ongoing discussions on this front.
Really pleased to see BBIs app
'Competition doesn't bother me in the least'... all about ramping up supply
AS: "competition does not bother me in the least"
120 m test per month Uk only
Supply multi factor
Saliva tube, pippete
Supply is the worry
This is exactly the transparency i have been talking about. If the market is comfortable with this price on this transparency then that starts to eliminate some downside risk.
Very interesting idea about the LFA tests being used at testing stations as triage to reduce the number of tests which need to be conducted by PCR...
I don't believe any of us had even considered that a possibility. Brilliant idea, though!
Great - smart phone app linked into healthcare systems
Visual test ie no machine. Very confident
Smart phone app to record result
Feed to data systems
Working with partners on smartphone app
Professional
Self cert first
Second consumer takes longer
Hospital market low cos pcr on site, but nurse in
Companies is good market for professional. Also doctors etc
My mate just text me to say
This is so positive!!!
Loosing this writing and listening
Presymptomatic is good????
Graph showing viral
Load verses infectious
High specificy regular testing needed
Sensitivity needed 90% or more
Basically numbers to show where value is
LFD ... do I have infection
Graph about infectioness verses having virus.
Pcr good for early but redial after recovery
7 days for antibody to late
Sweet spot when infected is most infectious
7/10 days after symptoms is where you want to see
Antigen is best
& travel light...
"significant commercial interest in BAMS test" despite "frustrating" CONDOR program
Now doing how BAMs works.
Showing a complicated mass spectrum graph. Finger print. Spot mutation.
Work has been slow trying to accelerate this with condor. Clinical validation Q4. Large commercial interests. Will goto market via mass spectrum seller
Keep it up travel light
Legend
Few thousand copies of virus in saliva.
Also very specific. No cross reactivity with common simulate virus
Here we go, watch the Blue coming
Alister say Elisa test best on market
Dose escalation safety etc 2021
Small number till max dose established.
Range of cancers in study.
Bigger Dose study 1, or 2 cancers in 2022 on back of part A
Assuming Alastairs banging the PREcision drum like he did in the last webinar after he got his hands on the £50m. Given the SP was pumped up on the back of the LFT, it's strange he always avoids mentioning it.
it did say it's being recorded so no issue with listening later
Sounds very good so far, apart from the boring cancer stuff ;)